Pfizer has vastly exceeded its Covid-19 vaccine sales forecast of $15bn, and now expects the jab to bring in $26bn of revenue in 2021 – an increase of 73% https://www.pharmaceutical-technology.com/features/pfizer-covid-19-vaccine-revenue/

J&J’s pharmaceutical business, which developed the single-shot Covid vaccine, generated $12.59 billion in revenue, a 17.2% year-over-year increase. https://www.cnbc.com/2021/07/21/johnson-johnson-jnj-earnings-q2-2021.html

Moderna had earnings of $1.2 billion, or $2.84 per share, in the first quarter of 2021. This is compared to a loss of $124 million, or 35 cents per share, in the first quarter a year ago. https://www.marketwatch.com/story/moderna-reports-17-billion-in-covid-19-vaccine-sales-posts-first-profit-ever-2021-05-06